LSTA logo

Lisata Therapeutics (LSTA) EBIT

Annual EBIT

-$25.71 M
+$31.89 M+55.37%

December 31, 2023


Summary


Performance

LSTA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAprofitabilitymetrics:

Quarterly EBIT

-$5.34 M
+$187.00 K+3.39%

September 30, 2024


Summary


Performance

LSTA Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAprofitabilitymetrics:

TTM EBIT

-$23.48 M
+$628.00 K+2.60%

September 30, 2024


Summary


Performance

LSTA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

LSTA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.4%+11.4%+8.7%
3 y3 years-34.3%+11.4%+8.7%
5 y5 years-59.0%+11.4%+8.7%

LSTA EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+55.4%at high+85.8%at high+59.5%
5 y5-year-34.3%+55.4%-31.5%+85.8%-26.9%+59.5%
alltimeall time<-9999.0%+73.3%-4220.6%+88.5%-8627.2%+75.6%

Lisata Therapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.34 M(-3.4%)
-$23.48 M(-2.6%)
Jun 2024
-
-$5.52 M(-16.3%)
-$24.11 M(-5.3%)
Mar 2024
-
-$6.60 M(+9.6%)
-$25.46 M(-0.9%)
Dec 2023
-$25.71 M(-55.4%)
-$6.03 M(+1.0%)
-$25.71 M(-2.0%)
Sep 2023
-
-$5.96 M(-13.3%)
-$26.22 M(-54.8%)
Jun 2023
-
-$6.88 M(+0.5%)
-$57.98 M(+0.3%)
Mar 2023
-
-$6.84 M(+4.6%)
-$57.82 M(+0.4%)
Dec 2022
-$57.60 M(+98.3%)
-$6.54 M(-82.7%)
-$57.60 M(-0.5%)
Sep 2022
-
-$37.72 M(+461.3%)
-$57.91 M(+113.2%)
Jun 2022
-
-$6.72 M(+1.5%)
-$27.16 M(-1.5%)
Mar 2022
-
-$6.62 M(-3.3%)
-$27.58 M(-5.0%)
Dec 2021
-$29.05 M(+51.7%)
-
-
Dec 2021
-
-$6.85 M(-1.7%)
-$29.05 M(+5.1%)
Sep 2021
-
-$6.97 M(-2.5%)
-$27.65 M(+6.2%)
Jun 2021
-
-$7.15 M(-11.6%)
-$26.03 M(+12.3%)
Mar 2021
-
-$8.09 M(+48.5%)
-$23.17 M(+21.0%)
Dec 2020
-$19.14 M(-4.7%)
-$5.45 M(+1.8%)
-$19.14 M(+1.9%)
Sep 2020
-
-$5.35 M(+24.7%)
-$18.78 M(+1.5%)
Jun 2020
-
-$4.29 M(+5.8%)
-$18.50 M(-5.4%)
Mar 2020
-
-$4.06 M(-20.2%)
-$19.56 M(-2.7%)
Dec 2019
-$20.09 M(+24.3%)
-$5.08 M(+0.2%)
-$20.09 M(+8.2%)
Sep 2019
-
-$5.07 M(-5.1%)
-$18.57 M(+8.9%)
Jun 2019
-
-$5.35 M(+16.4%)
-$17.04 M(+8.1%)
Mar 2019
-
-$4.59 M(+29.1%)
-$15.77 M(-2.4%)
Dec 2018
-$16.16 M(-40.8%)
-$3.56 M(+0.2%)
-$16.16 M(-18.3%)
Sep 2018
-
-$3.55 M(-12.9%)
-$19.79 M(-10.8%)
Jun 2018
-
-$4.08 M(-18.2%)
-$22.19 M(-14.1%)
Mar 2018
-
-$4.98 M(-30.7%)
-$25.82 M(-5.5%)
Dec 2017
-$27.32 M(-7.3%)
-$7.18 M(+20.7%)
-$27.32 M(+6.6%)
Sep 2017
-
-$5.95 M(-22.7%)
-$25.62 M(+0.9%)
Jun 2017
-
-$7.71 M(+19.0%)
-$25.39 M(+1.2%)
Mar 2017
-
-$6.48 M(+18.0%)
-$25.08 M(-15.5%)
Dec 2016
-$29.48 M(-69.3%)
-$5.49 M(-4.1%)
-$29.68 M(-58.0%)
Sep 2016
-
-$5.72 M(-22.6%)
-$70.57 M(-6.7%)
Jun 2016
-
-$7.40 M(-33.2%)
-$75.64 M(-14.6%)
Mar 2016
-
-$11.07 M(-76.1%)
-$88.56 M(-7.9%)
Dec 2015
-$96.13 M(+75.4%)
-$46.38 M(+329.8%)
-$96.13 M(+56.8%)
Sep 2015
-
-$10.79 M(-46.9%)
-$61.31 M(-9.1%)
Jun 2015
-
-$20.31 M(+9.0%)
-$67.46 M(+12.9%)
Mar 2015
-
-$18.63 M(+61.1%)
-$59.76 M(+9.0%)
Dec 2014
-$54.81 M(+42.7%)
-$11.56 M(-31.8%)
-$54.81 M(-1.4%)
Sep 2014
-
-$16.95 M(+34.3%)
-$55.61 M(+16.3%)
Jun 2014
-
-$12.62 M(-7.8%)
-$47.80 M(+10.4%)
Mar 2014
-
-$13.69 M(+10.8%)
-$43.29 M(+12.7%)
Dec 2013
-$38.42 M(+10.7%)
-$12.36 M(+35.3%)
-$38.42 M(+0.2%)
Sep 2013
-
-$9.13 M(+12.6%)
-$38.36 M(+2.6%)
Jun 2013
-
-$8.11 M(-8.0%)
-$37.39 M(+3.7%)
Mar 2013
-
-$8.82 M(-28.3%)
-$36.07 M(+3.9%)
Dec 2012
-$34.70 M(+8.7%)
-$12.29 M(+50.6%)
-$34.70 M(+24.5%)
Sep 2012
-
-$8.16 M(+20.3%)
-$27.88 M(+3.5%)
Jun 2012
-
-$6.79 M(-9.0%)
-$26.94 M(-9.1%)
Mar 2012
-
-$7.46 M(+36.3%)
-$29.64 M(+0.4%)
DateAnnualQuarterlyTTM
Dec 2011
-$31.92 M(+73.8%)
-$5.47 M(-24.4%)
-$29.51 M(-3.5%)
Sep 2011
-
-$7.23 M(-23.8%)
-$30.58 M(+5.3%)
Jun 2011
-
-$9.48 M(+29.5%)
-$29.05 M(+26.7%)
Mar 2011
-
-$7.33 M(+12.0%)
-$22.92 M(+24.8%)
Dec 2010
-$18.37 M(-29.1%)
-$6.54 M(+14.8%)
-$18.37 M(-23.4%)
Sep 2010
-
-$5.70 M(+69.9%)
-$23.99 M(-6.0%)
Jun 2010
-
-$3.35 M(+21.0%)
-$25.51 M(-5.0%)
Mar 2010
-
-$2.77 M(-77.2%)
-$26.84 M(+3.5%)
Dec 2009
-$25.89 M(+180.4%)
-$12.17 M(+68.5%)
-$25.93 M(+60.2%)
Sep 2009
-
-$7.22 M(+54.0%)
-$16.19 M(+48.7%)
Jun 2009
-
-$4.69 M(+152.4%)
-$10.89 M(+27.2%)
Mar 2009
-
-$1.86 M(-23.5%)
-$8.56 M(-7.2%)
Dec 2008
-$9.23 M(-11.6%)
-$2.43 M(+26.5%)
-$9.23 M(+1.0%)
Sep 2008
-
-$1.92 M(-18.7%)
-$9.14 M(-20.8%)
Jun 2008
-
-$2.36 M(-6.5%)
-$11.54 M(+3.6%)
Mar 2008
-
-$2.52 M(+7.9%)
-$11.14 M(+6.8%)
Dec 2007
-$10.44 M(+122.5%)
-$2.34 M(-45.9%)
-$10.44 M(+6.3%)
Sep 2007
-
-$4.32 M(+120.9%)
-$9.81 M(+51.2%)
Jun 2007
-
-$1.96 M(+7.6%)
-$6.49 M(+16.5%)
Mar 2007
-
-$1.82 M(+5.9%)
-$5.57 M(+18.8%)
Dec 2006
-$4.69 M(+193.0%)
-$1.72 M(+72.1%)
-$4.69 M(+35.4%)
Sep 2006
-
-$998.00 K(-3.8%)
-$3.46 M(+15.2%)
Jun 2006
-
-$1.04 M(+10.7%)
-$3.01 M(+29.3%)
Mar 2006
-
-$937.40 K(+91.1%)
-$2.33 M(+45.3%)
Dec 2005
-$1.60 M(+8.6%)
-$490.50 K(-9.5%)
-$1.60 M(+16.6%)
Sep 2005
-
-$542.10 K(+52.3%)
-$1.37 M(+10.0%)
Jun 2005
-
-$355.90 K(+67.6%)
-$1.25 M(-4.4%)
Mar 2005
-
-$212.40 K(-19.1%)
-$1.31 M(-11.4%)
Dec 2004
-$1.47 M(+64.9%)
-$262.60 K(-37.1%)
-$1.47 M(-6.8%)
Sep 2004
-
-$417.40 K(+1.0%)
-$1.58 M(+16.2%)
Jun 2004
-
-$413.30 K(+8.5%)
-$1.36 M(+18.1%)
Mar 2004
-
-$381.00 K(+3.1%)
-$1.15 M(+28.8%)
Dec 2003
-$894.30 K(-22.2%)
-$369.40 K(+87.7%)
-$894.40 K(+1.4%)
Sep 2003
-
-$196.80 K(-3.9%)
-$882.10 K(-3.1%)
Jun 2003
-
-$204.70 K(+65.7%)
-$910.30 K(+0.4%)
Mar 2003
-
-$123.50 K(-65.4%)
-$906.50 K(-21.1%)
Dec 2002
-$1.15 M(-28.4%)
-$357.10 K(+58.7%)
-$1.15 M(-7.4%)
Sep 2002
-
-$225.00 K(+12.0%)
-$1.24 M(-11.5%)
Jun 2002
-
-$200.90 K(-45.2%)
-$1.40 M(-9.8%)
Mar 2002
-
-$366.30 K(-18.5%)
-$1.55 M(-0.8%)
Dec 2001
-$1.61 M(-36.2%)
-$449.50 K(+16.6%)
-$1.57 M(-12.8%)
Sep 2001
-
-$385.60 K(+9.3%)
-$1.80 M(-26.4%)
Jun 2001
-
-$352.90 K(-6.7%)
-$2.44 M(-5.1%)
Mar 2001
-
-$378.20 K(-44.3%)
-$2.57 M(+4.4%)
Dec 2000
-$2.52 M(+146.1%)
-$679.40 K(-34.0%)
-$2.46 M(+38.1%)
Sep 2000
-
-$1.03 M(+113.1%)
-$1.78 M(+136.9%)
Jun 2000
-
-$483.10 K(+79.5%)
-$752.20 K(+179.5%)
Mar 2000
-
-$269.10 K
-$269.10 K
Dec 1999
-$1.02 M(+138.8%)
-
-
Dec 1998
-$428.20 K(+93.2%)
-
-
Mar 1998
-$221.60 K(-11.9%)
-
-
Mar 1997
-$251.60 K(-2.1%)
-
-
Mar 1996
-$257.10 K
-
-

FAQ

  • What is Lisata Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Lisata Therapeutics?
  • What is Lisata Therapeutics annual EBIT year-on-year change?
  • What is Lisata Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Lisata Therapeutics?
  • What is Lisata Therapeutics quarterly EBIT year-on-year change?
  • What is Lisata Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Lisata Therapeutics?
  • What is Lisata Therapeutics TTM EBIT year-on-year change?

What is Lisata Therapeutics annual earnings before interest & taxes?

The current annual EBIT of LSTA is -$25.71 M

What is the all time high annual EBIT for Lisata Therapeutics?

Lisata Therapeutics all-time high annual earnings before interest & taxes is -$221.60 K

What is Lisata Therapeutics annual EBIT year-on-year change?

Over the past year, LSTA annual earnings before interest & taxes has changed by +$31.89 M (+55.37%)

What is Lisata Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of LSTA is -$5.34 M

What is the all time high quarterly EBIT for Lisata Therapeutics?

Lisata Therapeutics all-time high quarterly earnings before interest & taxes is -$123.50 K

What is Lisata Therapeutics quarterly EBIT year-on-year change?

Over the past year, LSTA quarterly earnings before interest & taxes has changed by +$689.00 K (+11.44%)

What is Lisata Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of LSTA is -$23.48 M

What is the all time high TTM EBIT for Lisata Therapeutics?

Lisata Therapeutics all-time high TTM earnings before interest & taxes is -$269.10 K

What is Lisata Therapeutics TTM EBIT year-on-year change?

Over the past year, LSTA TTM earnings before interest & taxes has changed by +$2.22 M (+8.65%)